Koyfin Home > Directory > Health Care > Acorda Therapeutics > Net Income

Acorda Therapeutics Net Income Chart (ACOR)

Acorda Therapeutics annual/quarterly Net Income from 2010 to 2020. Net income is calculated as sales less cost of goods sold, selling, general and administrative expenses, operating expenses, depreciation, interest, taxes and other expenses. This number appears on a company's income statement and is an important measure of how profitable the company is.
  • Acorda Therapeutics Net Income for the quarter ending June 06, 2020 was $-17m a -1,412.74% increase of 246m year over year
  • Acorda Therapeutics Net Income for the last 12 months ending June 06, 2020 was $-222m a -48.37% increase of 107m year over year
  • Acorda Therapeutics Annual Net Income for 2019 was $-273m a 112.34% decrease of -307m from 2018
  • Acorda Therapeutics Annual Net Income for 2018 was $34m a 763.14% increase of 257m from 2017
  • Acorda Therapeutics Annual Net Income for 2017 was $-223m a 84.50% decrease of -189m from 2016
Other Income Statement Metrics:
  • Acorda Therapeutics EBITDA for the quarter ending December 12, 2018 was $-14m a 190.76% decrease of -26m year over year
  • Acorda Therapeutics Total Revenue for the quarter ending December 12, 2018 was $69m a -53.52% decrease of -37m year over year
View Chart On Koyfin

Quarterly ACOR Net Income Data

06/2020$-17m
03/2020$-6m
12/2019$66m
09/2019$-264m
06/2019$-27m
03/2019$-48m
12/2018$10m
09/2018$-14m
06/2018$46m
03/2018$-8m

Annual ACOR Net Income Data

2019$-273m
2018$34m
2017$-223m
2016$-35m
2015$11m
2014$18m
2013$16m
2012$155m
2011$31m
2010$-12m